Know Labs, Inc. (KNW)

NYSEAMERICAN: KNW · Real-Time Price · USD
0.230
0.00 (0.09%)
Nov 20, 2024, 4:00 PM EST - Market closed
0.09%
Market Cap 24.88M
Revenue (ttm) n/a
Net Income (ttm) -16.90M
Shares Out 108.10M
EPS (ttm) -0.20
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 55,096
Open 0.223
Previous Close 0.230
Day's Range 0.223 - 0.235
52-Week Range 0.180 - 0.940
Beta 1.56
Analysts Buy
Price Target 1.00 (+334.41%)
Earnings Date Nov 15, 2024

About KNW

Know Labs, Inc., together with its subsidiaries, focuses on the development and commercialization of proprietary sensor technology by radio and microwave spectroscopy in the United States. The company’s proprietary platform technologies include ChromaID and Bio-RFID technologies that utilizes electromagnetic energy to detect, record, identify, and measure the signature of said materials or analytes. The company was formerly known as Visualant, Incorporated and changed its name to Know Labs, Inc. in May 2018. Know Labs, Inc. was incorporated in ... [Read more]

Sector Technology
Founded 1998
Employees 11
Stock Exchange NYSEAMERICAN
Ticker Symbol KNW
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to one analyst, the rating for KNW stock is "Buy" and the 12-month stock price forecast is $1.0.

Price Target
$1.0
(334.41% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Know Labs Provides Overview of FY2024 10-K Annual Report

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), a leading developer of non-invasive diagnostics technology released this morning an overview of its Form 10-K annual report for its fisc...

2 days ago - Business Wire

Know Labs, Inc. Announces Receipt of Audit Opinion with Going Concern Explanation

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), leading developer of non-invasive diagnostics technology, today announced that, as previously disclosed in its Annual Report on Form 10-...

5 days ago - Business Wire

Know Labs, Inc. Reports Fourth Quarter and Fiscal Year 2024 Results

SEATTLE--(BUSINESS WIRE)--Know Labs, an emerging developer of non-invasive medical diagnostic technology, reported financial results for the Q4 and fiscal year of 2024.

5 days ago - Business Wire

Know Labs Announces Expanded Technology Leadership in its Executive Team

SEATTLE--(BUSINESS WIRE)--Know Labs Announces Expanded Technology Leadership in its Executive Team; Acceleration of Platform Development to Secure Strategic Partnerships.

4 weeks ago - Business Wire

Know Labs Sensor Technology in Steering Wheels Could Curb Impaired Driving

SEATTLE--(BUSINESS WIRE)--Know Labs Sensor Technology in Steering Wheels Could Curb Impaired Driving. Know Labs Retains Stanbridge Group to Secure Automotive JV Partnerships.

5 weeks ago - Business Wire

Know Labs Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards

SEATTLE--(BUSINESS WIRE)--Know Labs Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards. A Plan for Compliance has been undertaken.

7 weeks ago - Business Wire

Know Labs Study Published in IEEE Sensors Journal

SEATTLE--(BUSINESS WIRE)--Peer-reviewed journal publication validates Know Labs' proprietary technology and its application for non-invasive blood glucose monitoring.

2 months ago - Business Wire

Know Labs, Inc. Announces $1.655 Million Public Offering

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW) (the “Company”), a leading developer of non-invasive medical diagnostic technology, today announced that it has entered into definitive a...

3 months ago - Business Wire

Know Labs, Inc. (KNW) Q3 2024 Earnings Call Transcript

Know Labs, Inc. (NYSE:KNW) Q3 2024 Results Earnings Conference Call August 14, 2024 4:30 PM ET Company Participants Ron Erickson - Chairman and Chief Executive Officer Peter Conley - Chief Financial ...

3 months ago - Seeking Alpha

Know Labs, Inc. Reports Third Quarter FY 2024 Results

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), a leading developer of non-invasive medical diagnostic technology, today reported financial results for the third quarter of the fiscal ...

3 months ago - Business Wire

Know Labs, Inc. Announces Closing of $3.445 Million Public Offering

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), a leading developer of non-invasive medical diagnostics technology, today announced the successful closing of its previously announced u...

3 months ago - Business Wire

Know Labs, Inc. Announces Pricing of $3.445 Million Public Offering

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW) (the “Company”), a leading developer of non-invasive medical diagnostic technology, today announced the pricing of a firm commitment unde...

3 months ago - Business Wire

Sandbox VR Opens First Australian Location August 15 in Gold Coast

BRISBANE, Australia--(BUSINESS WIRE)--Sandbox VR, a full-body virtual reality entertainment experience, is pleased to announce the grand opening of its first Australian location on Thursday, August 15...

3 months ago - Business Wire

Know Labs, Inc. to Host Review of Third Quarter Fiscal Year 2024 Results on August 14, 2024

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), a leading developer of non-invasive medical diagnostic technology, today announced it will host a webcast to review business updates and...

3 months ago - Business Wire

Know Labs Publishes Clinical Results in Leading Diabetes Journal

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), a leading developer of non-invasive medical diagnostic technology, today announced the publication of its peer-reviewed study in Diabete...

4 months ago - Business Wire

Know Labs to Present at the American Diabetes Association's Scientific Sessions

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), a leading developer of non-invasive medical diagnostic technology, today announced further interim results from a clinical research stud...

5 months ago - Business Wire

Know Labs Joins the Industrial Participant Program of the Wyss Institute for Biologically Inspired Engineering at Harvard University

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), a leading developer of non-invasive medical diagnostic technology, today announced that it has joined the Industrial Participant Program...

6 months ago - Business Wire

Know Labs Appoints Chris Somogyi as President, International

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging leader in non-invasive medical diagnostic technology, today announced the appointment of Chris Somogyi as President, Interna...

6 months ago - Business Wire

Know Labs, Inc. (KNW) Q2 2024 Earnings Call Transcript

Know Labs, Inc. (NYSE:KNW) Q2 2024 Earnings Conference Call May 15, 2024 4:30 PM ET Company Participants Jordyn Hujar - Chief of Staff Ron Erickson - Chief Executive Officer Peter Conley - Chief Fina...

6 months ago - Seeking Alpha

Know Labs, Inc. Reports Second Quarter FY 2024 Results

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), a leading developer of non-invasive medical diagnostic technology, today reported financial results for the second quarter of the fiscal...

6 months ago - Business Wire

Know Labs to Present Clinical Research at the 2024 American Association of Clinical Endocrinology Annual Meeting

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced it has been selected for an oral abstract presentat...

6 months ago - Business Wire

Know Labs, Inc. to Host Review of Second Quarter Fiscal Year 2024 Results on May 15, 2024

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced it will host a webcast to review business updates a...

7 months ago - Business Wire

Know Labs to Present Clinical Research at the 2024 American Physiology Summit

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced it has been selected for an abstract poster present...

8 months ago - Business Wire

Know Labs' Non-Invasive Glucose Monitor Achieves 11.1% MARD in Latest Clinical Research Study

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced interim results from its most recent clinical resea...

9 months ago - Business Wire

Know Labs Secures U.S. $12 Million Funding for Company's Further Execution on Its Clinical Research and Development Initiatives

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced it has entered into a funding agreement for an inve...

9 months ago - Business Wire